Susquehanna International Group
PHXM

Susquehanna International Group’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Susquehanna International Group’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,101
Closed -$6K – 14089
2022
Q3 		$6K Buy
+1,101
New +$10.9K ﹤0.01% 12867
2022
Q1 		– Sell
-2,071
Closed -$39.2K – 14250
2021
Q4 		$49K Sell
2,071
-486
-19% -$16.4K ﹤0.01% 12562
2021
Q3 		$148K Buy
+2,557
New +$143K ﹤0.01% 11809

Other funds holding PHXM

JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Susquehanna International Group's PHXM Position: Q4 2022 in Review

Susquehanna International Group sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q4 2022, closing a stake of 1,101 shares — an estimated $6K sold.

Susquehanna International Group first reported a position in PHXM in Q3 2021 and held it in 3 quarters. The position peaked at $148K in Q3 2021. 8 funds tracked by Wall St. Rank hold PHXM as of Q4 2022.

  • Susquehanna International Group reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 1,101 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q4 2022, an estimated $6K.
  • Susquehanna International Group first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q3 2021 and held it in 3 quarters.
  • Susquehanna International Group's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $148K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.